Back to top

Image: Bigstock

Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline

Read MoreHide Full Article
Inovio Pharmaceuticals, Inc. (INO - Free Report) announced that it has licensed a veterinary vaccine for the treatment of foot and mouth disease (FMD) to a South Korean animal health company, Plumbline Life Sciences.
 
Inovio will get milestone payments as well as royalties from Plumbline on product sales of the FMD synthetic vaccine in Asia, excluding Japan. Plumbline will also fund all development activities related to the vaccine.
 
Per Inovio’s press release, FMD is one of the most infectious diseases affecting farm animals including cattle, swine, sheep and goats, and is therefore a serious threat to global food safety. Considering that the disease can spread rapidly and beyond regional boundaries, there is urgent need to develop vaccines that can simultaneously target different regional serotypes of FMD in a single vaccine.
 
Inovio’s FMD DNA vaccine has demonstrated potential to prevent the virus from infecting livestock animals in previous studies and thus may be a global solution. Moreover, Inovio's SynCon technology will allow rapid development of vaccines that can cover multiple serotypes simultaneously with a single formulation.

INOVIO PHARMAC Price

INOVIO PHARMAC Price | INOVIO PHARMAC Quote

We note that this is Inovio’s second license agreement with Plumbline for the development of animal health products and market opportunities. In 2014, Inovio had sold other animal health assets to Plumbline for cash and a significant equity position in the company.

We are positive on the latest development. It will not only help Inovio monetize non-core assets but will also allow the company to focus on human immunotherapies to help fight cancers and infectious diseases.

Inovio currently has a Zacks Rank #4 (Sell). Some better-ranked stocks in the health care sector include Geron Corporation (GERN - Free Report) , Anika Therapeutics Inc. (ANIK - Free Report) and ANI Pharmaceuticals, Inc. (ANIP - Free Report) . All three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Unique Zacks Analysis of Your Chosen Ticker


Pick one free report - opportunity may be withdrawn at any time


Geron Corporation (GERN) - $25 value - yours FREE >>

Inovio Pharmaceuticals, Inc. (INO) - $25 value - yours FREE >>

Anika Therapeutics Inc. (ANIK) - $25 value - yours FREE >>

ANI Pharmaceuticals, Inc. (ANIP) - $25 value - yours FREE >>

Published in

Analyst Blog: Company News - Medical